Glaukos Corporation GKOS is well-poised for growth on the back of favorable clinical trial results and a robust product ...

Baxter International BAX announced the launch of Hemopatch Sealing Hemostat in the United States. This innovative, ...

▪ Malls: Aventura Mall, Dolphin Mall and the Simon-owned malls (Dadeland Mall, The Falls, Florida Keys Outlet Marketplace, ...

Letters published May 13-19, 2025, deal with research funding, drug prices and what God says about diversity and dignity.

THE NBA'S MOST FAMOUS PLAYER showcases the league's best-known example of sideline skin care before every Lakers game, when ...

Health insurance companies have been in the limelight lately after UnitedHealthcare suspended its guidance for the full year ...

The stock's fall snapped a four-day winning streak.

Health care stocks are tanking in Wednesday's extended trading after CMS announced a significant expansion of its auditing ...

On May 19, Guy P Sansone, Board Member at CVS Health CVS +0.19% Get Free Report executed a significant insider buy, as disclosed in the latest SEC filing.

CVS HEALTH CORP (CVS) is a large-cap value stock in the Retail (Drugs) industry. The rating using this strategy is 100% based on the firm’s underlying fundamentals and the stock’s valuation.

Hotchkis & Wiley, an investment management company, released its “Hotchkis & Wiley Mid-Cap Value Fund” first quarter 2025 ...

CVS Health (CVS) stock gains as the company bids for Rite Aid's (RADCQ) stores and assets in the Pacific Northwest. Read more ...